| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Linthwaite Stephen Christopher is a President &CEO at LAB. Recent filings cover 3 purchases and 1 sale. Those positions are worth an estimated $273K at current prices.
Linthwaite Stephen Christopher's largest disclosed position is in LAB as President &CEO, worth about $273K. Net of sales, the recent Form 4 record there shows accumulation of 19,180 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2020 | LAB Standard Biotools Inc. | President &CEO | Sale+OE | 84,820 | $6.06 | $514,009.20 | -36.9% | |
| Aug 23, 2019 | LAB Standard Biotools Inc. | President &CEO | Buy | 4,000 | $5.52 | $22,077.20 | +2.4% | |
| Aug 8, 2017 | LAB Standard Biotools Inc. | President &CEO | Buy | 45,000 | $2.66 | $119,884.50 | +72.6% | |
| Nov 30, 2016 | LAB Standard Biotools Inc. | President &CEO | Buy | 55,000 | $6.36 | $350,064.00 | +1,833% |